Literature DB >> 3898859

Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease.

W Timens, S Poppema.   

Abstract

A panel of monoclonal antibodies directed against T and B lymphocyte antigens was used to analyze the presence and localization of several lymphocyte subsets in 13 normal human spleens (3 of newborns) and 17 uninvolved spleens of patients with Hodgkin's disease. The distribution of cells in the white pulp corresponded with findings in other secondary lymphoid organs, except for the presence of a marginal zone, a unique compartment localized at the border of white and red pulp. The phenotype of the marginal zone cells indicates that it is likely that the marginal zone contains nonrecirculating as well as recirculating B cells, while T cells (of the T helper type) are also represented. Therefore, the notion that marginal zone cells are nonrecirculating IgM+, IgD- cells, appears to be an oversimplification. No clear differences were observed between spleens of patients with and without Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3898859      PMCID: PMC1887979     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.

Authors:  D C Case; J A Hansen; E Corrales; C W Young; B Dupont; C M Pinsky; R A Good
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

2.  Marginal zone and germinal center development in the spleens of neonatally thymectomized and nonthymectomized young rats.

Authors:  J C Pettersen; R J Rose
Journal:  Am J Anat       Date:  1968-11

3.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

4.  A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.

Authors:  C S Abramson; J H Kersey; T W LeBien
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

5.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  Subpopulations of human T lymphocytes. XVI. Maldistribution of T cell subsets associated with abnormal locomotion of T cells in untreated adult patients with Hodgkin's disease.

Authors:  S Gupta
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

7.  Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas.

Authors:  H Stein; A Bonk; G Tolksdorf; K Lennert; H Rodt; J Gerdes
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

8.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  A unique cell surface antigen identifying lymphoid malignancies of B cell origin.

Authors:  L M Nadler; J Ritz; R Hardy; J M Pesando; S F Schlossman; P Stashenko
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  Distribution of T cell subsets in human lymph nodes.

Authors:  S Poppema; A K Bhan; E L Reinherz; R T McCluskey; S F Schlossman
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  24 in total

1.  Splenic marginal zone lymphomas appear to originate from different B cell types.

Authors:  David W Bahler; J Ander Pindzola; Steven H Swerdlow
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 2.  The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens.

Authors:  A Zandvoort; W Timens
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

3.  Fetal and early post-natal development of the human spleen: from primordial arterial B cell lobules to a non-segmented organ.

Authors:  Birte Steiniger; Norbert Ulfig; Manfred Risse; Peter J Barth
Journal:  Histochem Cell Biol       Date:  2007-07-12       Impact factor: 4.304

4.  Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells.

Authors:  W Timens; A Boes; H Vos; S Poppema
Journal:  Histochemistry       Date:  1991

Review 5.  Phenotypic and functional heterogeneity of human memory B cells.

Authors:  Iñaki Sanz; Chungwen Wei; F Eun-Hyung Lee; Jennifer Anolik
Journal:  Semin Immunol       Date:  2008-02-06       Impact factor: 11.130

Review 6.  The splenic marginal zone in humans and rodents: an enigmatic compartment and its inhabitants.

Authors:  Birte Steiniger; Eva Maria Timphus; Peter J Barth
Journal:  Histochem Cell Biol       Date:  2006-07-01       Impact factor: 4.304

7.  The follicular dendritic cell network in secondary follicles of human palatine tonsils and spleens.

Authors:  Birte Steiniger; Marc Trabandt; Peter J Barth
Journal:  Histochem Cell Biol       Date:  2011-03-11       Impact factor: 4.304

Review 8.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

9.  Immunoarchitecture of regenerated splenic transplants: influence of donor and host age on the regeneration of splenic compartments.

Authors:  J Westermann; P Peschel; R Pabst
Journal:  Cell Tissue Res       Date:  1988-11       Impact factor: 5.249

10.  Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect.

Authors:  W Timens; R Leemans
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.